C-FLEX MODEL 570C INTRAOCULAR LENS (IOL)
Rayner Intraocular Lenses , Ltd. · Decision date May 3, 2007
What did the FDA approve?
The FDA database entry records an original PMA approval for the C-FLEX Model 570C intraocular lens from Rayner Intraocular Lenses, Ltd. The stated purpose is primary implantation for visual correction of aphakia in adults after cataract removal by phacoemulsification, with the lens intended for placement in the capsular bag.
The entry does not include a supplement type or supplement reason, so no changed item or modification to a prior approval is described. The source statement reports the approved indication and intended placement but does not provide clinical data, safety findings, or effectiveness conclusions.
FDA approval order statement
APPROVAL FOR THE C-FLEX MODEL 570C INTRAOCULAR LENS (IOL). THE DEVICE IS INDICATED FOR PRIMARY IMPLANTATION FOR THE VISUAL CORRECTION OF APHAKIA IN ADULTS IN WHOM A CATARACTOUS LENS HAS BEEN REMOVED BY PHACOEMULSIFICA-TION. THE LENS IS INTENDED TO BE PLACE IN THE CAPSULAR BAG.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Ophthalmic
- Decision date
- May 3, 2007
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P060011
- Regulatory pathway
- Premarket approval application
- Applicant
- Rayner Intraocular Lenses , Ltd.
- Product code
- HQL
- Decision code
- APPR
- Decision date
- May 3, 2007
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: intraocular lens.
- Applicant
- Rayner Intraocular Lenses , Ltd.
- Product code
- HQL
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P060011 received
Application receipt date recorded by FDA.
P060011 · FDA decision
APPR
P060011/S045 · Related supplement
RayOne Galaxy; Model RAO605G, RayOne Galaxy Toric; Model RAO615X
Timeline entries are records held by MedtechLedger for P060011. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P060011
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Rayner Intraocular Lenses , Ltd. | PMA supplement | Sep 24, 2026 | FDA |
Explore the linked device profile
Other records with product code HQL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
FINEVISION HP Trifocal IOLsP240038/S004 | Beaver-Visitec International, Inc. | PMA supplement | Oct 27, 2026 | FDA |
CT LUCIA Intraocular Lenses (IOLs)P100016/S028 | Carl Zeiss Meditec Production, LLC | PMA supplement | Oct 23, 2026 | FDA |
enVista Hydrophobic Acrylic Intraocular LensP910056/S067 | Bausch + Lomb, Inc. | PMA supplement | Oct 23, 2026 | FDA |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Rayner Intraocular Lenses , Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 1-2 Sackville Trading Estate,, Sackville Rd., Hove, E. Sussex, BN3 7AN
Sources and methodology
- Original FDA record: P060011
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




